Speaker with ABC List
Before starting her career at Novartis Pharma, Ann Aerts served as Director of the Lung and Tuberculosis Association in Belgium, as Head of the Health Services Department of the International Committee of the Red Cross (ICRC) in Geneva, and as Health Coordinator for the ICRC in several countries. She holds degrees in Medicine, Public Health and Tropical Medicine.
A trained historian, he is Rector of the Istanbul University and Chairman of the Board of Overseers of the Haliç University.
George Alberti has had a longstanding interest in diabetes and metabolism. He has worked extensively in Tanzania and Mauritius. He has particular interests in the metabolic syndrome and also diagnostic tests for diabetes & has participated in several WHO Expert Committees and working groups relating to diabetes. He has published more than 1100 papers and chapters.
He is a veteran of the company, having joined in 1996 as a pharmaceutical consultant immediately after graduating from university with a biology degree. He then worked his way up the ranks in Germany including Head of Primary Care and Head of the company's Sales organization.
A Professor of Educational Sociology and Labor Market Research, Jutta Allmendinger is a former Director of the Institute of Employment Research (Nuremberg), Professor of Sociology at the Ludwig-Maximilians-University (Munich), and a Fellow at Harvard Business School’s Program for Organizational Behavior (Cambridge). She has authored various monographs and discussion papers, and received several awards for her outstanding work.
After graduating from Medicine in Alexandria, he practiced medicine in Scotland and obtained his postgraduate training and qualifications in the UK. Following his return to Iraq he held several positions in clinical and academic medicine and public health. He was Professor and Dean of the Faculty of Medicine, Mustansiriya University, Baghdad, and used to serve as WHO Assistant Director-General for Noncommunicable Diseases and Mental Health.
After serving as Chair of the Agency’s Board of Governors, Yukiya Amano was Japan's Resident Representative to the Agency from 2005 until his election as Director General in 2009. He has extensive experience in disarmament and non-proliferation diplomacy, as well as nuclear energy issues, and was Director-General for the Disarmament, Non-Proliferation and Science Department at the Japanese Foreign Ministry from 2002-2005.
Dr. Marie Archambault received her Doctor of Veterinary Medicine degree from the University of Montreal in 1993. She obtained an MSc in Veterinary Pathology and Microbiology in 1995, a PhD in Microbiology and Immunology in 2000. From 1999 to 2004, she was the head bacteriologist at the Animal Health Laboratory of the University of Guelph where she was also an Adjunct Faculty member. She joined the University of Montreal as a Faculty member in 2004. Her areas of research include antibiotic resistance in veterinary and zoonotic pathogens. Her Natural Sciences and Engineering Research Council of Canada (NSERC) research program is on the investigations into the association between antibiotic resistance and virulence factors of Gram-positive organisms with a focus on Clostridium perfringens. She has also developed a strong research program on Livestock-Associated-Methicillin-Resistant Staphylococcus aureus with the government of Quebec. She is the author/co-author of more than 40 publications in peer-reviewed scientific journals on the topic of antibiotic resistance. She also co-edited the second edition of the Clinical Veterinary Microbiology textbook.
From 2006-2013, Professor Atun was Head of the Health Management Group at Imperial College London. From 2008-2012 he served as a member of the Executive Management Team of The Global Fund to Fight AIDS, Tuberculosis and Malaria as the Director of Strategy, Performance and Evaluation Cluster. His research focuses on the design and implementation of health systems transformations and their impact on outcomes.
Professor José Otávio Auler is specialized in anesthesiology and in intensive care. His clinical research activities focus on fluid restitution, hemodynamic monitoring, mechanical ventilation, sepsis, patients at high surgical risk and experimental hemodilution.
Clare Bambra PhD is Professor of Public Health Newcastle University Medical School (UK). Her research focuses on the health effects of labour markets, health and welfare systems, as well as the role of public policies to reduce health inequalities. She has published extensively including How Politics Makes Us Sick: Neoliberal Epidemics (Palgrave Macmillan, 2015) and Health Divides: Where you live can kill you (Policy Press, 2016). She can be followed on Twitter @ProfBambra
Christian Baron received a Ph.D. in Microbiology at the Ludwig-Maximilians University in Munich in August Böck’s group in the Department of Microbiology in 1993, followed by postdoctoral research with Patricia C. Zambryski at UC Berkeley (CA, USA). In 1997 he returned to Munich as University Assistant to build his independent research group in the Department of Microbiology and in 2002 he was recruited as Associate Professor in the Biology Department at McMaster University in Hamilton (ON, Canada). In 2008 he joined the Department of Biochemistry at the Université de Montréal (QC, Canada) as Full Professor and Chair. In 2015 he was nominated as Vice-Dean of Research and Development at the Faculty of Medicine.
Dr Gaétan Barrette is Quebec’s Minister of Health and Social Services since 2014. A 1985 graduate in medicine of l’Université de Montréal, Dr Gaétan Barrette became a member of Royal College of Physicians and Surgeons of Canada in 1989. In 1991, he pursued a Fellowship in Vascular and Surgical Radiology at the University of California, San Diego. He currently practises at Maisonneuve-Rosemont hospital where he has been an active member since 1990. Dr. Barrette has been President of the Fédération des médecins spécialistes du Québec between 2006 and 2014. He was also Chairman of the Board of the Financière des professionnels inc. which manages a $2 billion portfolio. He was also a member of the Boards of the Régie de l’assurance maladie du Québec (RAMQ). Dr Barrette participates regularly in various conferences and forums on the subject of specialized medicine throughout Quebec, across Canada and abroad.
After studying economics he joined Bayer in the Corporate Finance Department. He held several international positions in the company, including member of the Executive Committee and Head of Central Administration & Organization at Bayer HealthCare and Chief Financial Officer of Bayer AG.
Associate professor, School of Industrial Relations, Université de Montréal
Nancy Beauregard, holds a PhD in population health from University of Ottawa. She is an associate professor at the School of Industrial Relations, University of Montreal. She is also a regular researcher at the Institut de recherche en santé publique de l’Université de Montréal (IRSPUM). Nancy Beauregard is interested in the influence of organizational context, and in particular, of the organizational learning process, on occupational health and safety. In addition, her recent work focuses on the association between work injuries and mental health among the workforce. Her researches on at risk industrial sectors and occupations have received financial support from the Institut de recherche Robert-Sauvé en santé et en sécurité du travail (IRSST). Hence, the theme of agricultural health and safety crosses her main research interests.
Dr. Marcel Behr is Professor of Medicine at McGill University where he is Director of the McGill International TB Centre and Microbiologist-in-Chief of the McGill University Health Centre. His training included BSc (Biochemistry) from the University of Toronto, MD from Queen’s University, Residency training in Infectious Diseases and Medical Microbiology at McGill, an MSc (Epidemiology) from McGill and then post-doctoral studies of Molecular Epidemiology and Bacterial Genomics at Stanford. Dr. Behr’s research interest is the application of bacterial genetics to study the epidemiology and pathogenesis of mycobacterial diseases, specifically, M. tuberculosis, BCG, and non-tuberculous mycobacteria, including members of the M. avium-intracellular complex. This work has been recognized by numerous awards, in Quebec (Chercheur National of the Fonds de la Recherche en Sante du Quebec) and beyond (Fellow of the Canadian Academy of Health Sciences, 2016 and Election to the American Society for Clinical Investigation, 2010).
Professor Robin Bell MBBS (Hons) PhD MPH FAFPHM Grad Cert Health Professional Education. Professor Robin Bell is the Deputy Director of the Women’s Health Research Program in the School of Public Health and Preventive Medicine at Monash University in Melbourne, Victoria, Australia. Professor Bell is a medical epidemiologist specializing in the health of women at midlife and older and has published 180 peer reviewed publications. Professor Bell is also the Curriculum and Assessment Lead for one of the 4 vertical themes in the medical course at Monash, the theme of Society, Population, Health and Illness. Professor Bell teaches population health, health promotion and prevention science as well as a module on the health of women at midlife. Monash University currently has an undergraduate medical course, a post-graduate course and a separate campus with a medical course in Malaysia. There are, in total, about 500 students in each year level of the medical courses at Monash.
A physician specialized in tropical medicine and public health, he was one of the founding board members of the Global Fund in 2002 and has served in his current position since 2003. Prior to joining the Global Fund, he worked as a clinician and public health official in the UK, Germany and as Doctor-in-Charge of a rural hospital in Tanzania. He has more than 25 years of experience in global health and health advocacy with a special focus on AIDS and infectious diseases.
Formally the Senior Vice President and CFO for Philips Home Healthcare Solutions, he joined Philips from Baxter Healthcare, where he acted as the European Regional Controller. He accumulated more than 20 years of experience in the healthcare industry, recently completing about 25 M&A transactions with a particular focus on targets in the areas of Home Healthcare, Clinical Decision Support, Imaging and Image Guided Intervention and Treatment.
Victoria is Chair of the Australian Medical Students’ Association, a graduate of Monash University, and is a junior doctor at the Alfred Hospital in Melbourne. She has been heavily involved in medical leadership and particularly in the wellbeing and rights of medical students. She has advocated locally, nationally and internationally for the mental health of medical students as President of the Monash University Medical Society where she worked on bullying advocacy as well as whistleblowing and reporting procedures. On an international level, Victoria worked as the inaugural Mental Health Program Coordinator for the International Federation of Medical Students’ Associations, discussing experiences with and creating tools for students from around the world.
She is passionate about non-formal education in the medical curriculum and believes that to learn broadly and with enthusiasm in fields beyond medicine will make students more holistic, empowered, people-focussed doctors, with greater influence to enact change within our societies.
Since January 2012, Alain Berset has been a member of the Swiss Federal Council, the seven-member Swiss government, and head of the Federal Department of Home Affairs. He studied political science and economics, and has authored several books on economic development, migration and regional development.
Elizabeth Blackburn won the 2009 Nobel Prize in Physiology or Medicine for discovering the molecular nature of telomeres and the co-discovery of telomerase. Both telomeres and telomerase are thought to play central roles in aging and diseases such as cancer. She has shown an abiding commitment to public service in the scientific, academic and public policy arenas, and helped to guide public science policy.
Carlos Blanco, M.D., Ph.D., M.S. is the Director of the Division of Epidemiology, Services, and Prevention Research at the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. Dr. Blanco is a national known expert in the epidemiology and treatment of addictive disorders with and without comorbid disorders. His accomplishments include, among others, a detailed examination of the course and stages of substance use disorders, the development of methods to quantify the generalizability of clinical trials, the development and testing of interventions that combine motivational interviewing with cognitive-behavioral therapy to improve retention and outcome in individuals with addictive disorders, and the creation of a virtual map of psychiatric disorders, based on empirical data, to guide research into the causes of mental disorders. Prior to joining NIDA, Dr. Blanco was Professor of Psychiatry at Columbia University Medical Center and a Research Psychiatrist at the New York State Psychiatric Institute.
Dr. Blouin serves as Secretary for the Committee on Accreditation of Canadian Medical Schools (CACMS) and for the Committee on Accreditation of Continuing Medical Education (CACME). She still maintains an active academic clinical practice in Emergency Medicine at Queen’s University, and was granted professorship in 2012. In 2003, she completed a Master of Health Professions Education degree at the University of Illinois at Chicago, followed in 2016 by a doctorate degree in Curriculum and Instruction from the same university. She has been involved as an educator and scholar in numerous projects at the provincial, national and international levels. Her research interests centre on curriculum development and program evaluation.
He was previously the Parliamentary Under Secretary of State at the Department of Health, where he was responsible for social services and mental health. Within this role he published guidelines to end the denial of adoptions purely on the basis of race.